Sleep pattern changes in patients with connective tissue diseases  by Efat, Emad
Egyptian Journal of Chest Diseases and Tuberculosis (2016) 65, 655–660HO ST E D  BY
The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLESleep pattern changes in patients with connective
tissue diseases* Tel.: +20 483848451.
E-mail address: emadefat@ymail.com
Peer review under responsibility of The Egyptian Society of Chest
Diseases and Tuberculosis.
http://dx.doi.org/10.1016/j.ejcdt.2016.01.015
0422-7638  2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Emad Efat *Chest, Faculty of Medicine, Menouﬁa University, Subk El Dahak, El Bajour, Menouﬁa, EgyptReceived 24 December 2015; accepted 21 January 2016
Available online 18 May 2016KEYWORDS
Sleep disorders;
Connective tissue diseases;
Obstructive sleep apnea;
Apnea hypopnea index;
C-reactive protein and rheu-
matic disordersAbstract Objectives: To assess sleep pattern changes in patients with connective tissue diseases.
Background: There is evidence that patients with rheumatic disorders may be at an increased risk
for sleep disorders, particularly obstructive sleep apnea (OSA). Sleep abnormalities have also been
linked to increased pain and fatigue perception, which are common concerns in rheumatology
patients. Untreated OSA with intermittent hypoxia is associated with elevated levels of systemic
inflammatory markers: C-reactive protein (CRP) and pro-inflammatory cytokines.
Methods: Thirty patients diagnosed as connective tissue diseases (CTD), and 30 apparent
healthy control subjects were invited to participate in the study. All the patients were subjected
to full medical history, Epworth sleepiness score (ESS), thorough clinical examination with evaluation
of the disease activity, laboratory assessment of CRP, and Complete overnight polysomnography.
Results: In the current work, the prevalence of Sleep apnea in CTD patients was 18/30(60%).
Sleep apnea was obstructive. Mean AHI (apnea–hypopnea index) was 23.42 ± 26.27/h. Among
these OSA patients, 36.7% had severe, 10% had moderate, and 36.7% had mild OSA. The study
showed a significant correlation between AHI and BMI, Neck circumference, ESS, erythrocyte sed-
imentation rate (ESR), CRP, and hematocrit (HCT).
Conclusion: Obstructive sleep apnea is commonly associated with CTD patients. Co-existence of
OSA in CTD patients may influence the disease activity and the level of circulating inflammatory
markers.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Connective tissue disorders (CTDs) are defined as a group of
acquired diseases resulting from persistent immune mediatedinflammation. In most CTDs there is immune dysregulation
resulting in generation of autoreactive T cells or autoantibod-
ies [1].
Sleep abnormalities have been recognized in a number of
different rheumatic diseases, including rheumatoid arthritis,
osteoarthritis, fibromyalgia, juvenile idiopathic arthritis, Sjo¨g-
ren’s syndrome, systemic lupus erythematosus, scleroderma,
spondyloarthritis, sarcoidosis and Behcet’s syndrome [2].
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ized by recurrent narrowing and closure of the upper airway
accompanied by intermittent oxyhemoglobin desaturation
and sympathetic activation [3]. The presence of sleep apnea
as a comorbidity may interfere with the evaluation of rheu-
matic disease activity and responsiveness to therapy [4].
Aim of the work
The aim of our study is to assess sleep pattern changes in
patients with connective tissue diseases.
Patients and methods
Thirty patients diagnosed as CTDs attending to outpatient
Immunology and Rheumatology clinic of Internal Medicine
Department and outpatient clinic of Rheumatology Depart-
ment of Menoufia University Hospital, and 30 apparent
healthy control subjects were invited to participate in the study.
This study included 60 subjects; they were divided into two
groups:
Group 1: consists of 30 patients who were diagnosed as
CTD patients and on a regular medication regimen for CTD.
Group 2: consists of 30 apparent healthy subjects. Complete
medical history was obtained; they were clinically free from
any known CTDs.
Health Research Ethics Board of Menoufia University
approved the study. Informed consent was obtained from all
participants, each patient underwent:
1. Detailed clinical evaluation including history talking, gen-
eral and local rheumatological examination.
2. Disease activity scores [the systemic lupus erythematosus
(SLE) Disease Activity Index (SLEDAI) [5] and Disease
Activity Score 28 (DAS28) [6]] for SLE & RA respectively.
3. Epworth sleepiness score (ESS).
4. Investigations:
1. Chest X-ray (posteroanterior and lateral views).
2. Electrocardiogram (ECG), echocardiography and
High-resolution CT chest if needed.
3. Routine laboratory investigations and immunological
profile.
4. Complete overnight polysomnography (PSG):It was conducted in the sleep laboratory unit, Chest
Department, Menoufia University Hospital over a whole night
(8 h sleep). We started the study at 10 P.M. until 6 A.M. using
EMBLA S 4000 system (Iceland).
The PSG consisted of Somnologica studio software, elec-
troencephalography sensor with its cables, electrooculography
electrodes, electromyography electrodes for the chin and
anterior tibialis muscle, Nasal canula and nasal thermistor,
Thoracic and abdominal belt, Pulse oximetry sensor, electro-
cardiography electrodes with their cables, Snoring micro-
phone, and Body position sensor (see Graph 5).
Data obtained from this study were:
- Apnea index (AI): Complete cessation of airflow breathing
at the nostrils and mouth for at least 10 s or longer.
- Hypopnea index (HI): A decrease in rate and depth of
breathing by 50% for 10 s or longer.- Apnea–hypopnea index (AHI): Average number of apnea
and hypopnea per hour of sleep. Persons with an
AHI < 5 are not considered to have OSA. In contrast, an
AHIP 5 and < 15, AHIP 15 and < 30, and an
AHIP 30 are classified as mild, moderate, and severe
respectively [7].
Results
Table 1 shows that:
Group 1 (cases): included 11 males (36.7%) and 19 females
(63.3%), the age ranged from 23 to 74 years with a mean
± SD value of 41.87 ± 15.01 years, the Body mass index
(BMI) of the patients ranged from 19.1 to 58.6 kg/m2 with a
mean ± SD value of 35.74 ± 11.20 kg/m2.
Group 2 (control): included 12 males (40.0%) and 18
females (60.0%), the age ranged from 33 to 83 years with a
mean ± SD value of 52.50 ± 12.39 years, the BMI of the
subjects ranged from 20 to 60 kg/m2 with a mean ± SD value
of 31.0 ± 9.39 kg/m2.
Table 2 shows a statistical significant difference between all
patients & control group as regard Epworth sleepiness scale
(ESS) and significant difference between them as regard Neck
circumference and smoking.
Table 3 displays Polysomnography parameters across the
studied groups that shows:
Total sleep time (TST), Sleep efficiency, REM Latency
from Sleep Onset, Spontaneous Arousals Index, PLMS
sequences, AHI, Oxygen Desaturation Events (OD), percent-
age of Snoring Time in TST, and Total AHI in NREM were
significantly different in the cases compared with control
group. There were no significant differences in Sleep Onset,
flow limitation index,% of sleep in supine position, A + H/h
in supine position, Average Oxygen Saturation, (%) of Lowest
Oxygen Saturation, % of REM in TST, and Total AHI in
REM across two groups.
Table 4 shows Sleep disorders by AHI, cases were sub-
divided according to results of polysomnography into:
Mild OSA (AHIP 5 and <15): consisted of 4/30(13.3%)
patients, moderate OSA (AHIP 15 and <30): consisted of
3/30(10%) patients, severe OSA (AHIP 30): consisted of
11/30(36.7%) patients, negative (AHI < 5): consisted of
12/30(40%) patients without OSA.
Table 5 shows a significant positive correlation between
AHI in patients and age, uric acid, and creatinine. In addition,
there were highly significant positive correlations between AHI
in patients and BMI, Neck circumference, ESS, ESR, CRP,
and HCT.
Table 6 shows a significant positive correlation between OD
in patients and age and Neck circumference. In addition, there
were highly significant positive correlations between OD in
patients and BMI, ESS, ESR, CRP, and HCT.
Table 7 shows the binary logistic regression model for risk
factors of sleep related breathing disorders (SRBD), which
demonstrates that ESR is independent risk factors for, SRBD
with odds ratio 1.90 and CI (1.01–4.55).
Discussion
Sleep disorders have been described in more than 75% of sub-
jects suffering from various forms of rheumatic diseases [8].
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Graph 5 Correlation between C-reactive protein (CRP) and apnea hypopnea index (AHI).
Table 1 Age, sex and BMI distribution among cases and control.
The studied cases Test of sig. P value
Cases Control
N= 30 N= 30
Age (year)
X± SD 41.87 ± 15.01 46.10 ± 8.01 U
Range 23–74 33–66 1.75 0.08
BMI (kg/m2)
X± SD 35.74 ± 11.20 31.0 ± 9.39 t-Test
Range 19.1–58.6 20–60 1.78 0.08
No % No %
Sex
Male 11 36.7 12 40.0 X2
Female 19 63.3 18 60.0 0.07 0.79
Table 2 Clinical data among cases and control.
The studied cases Test of sig. P value
Cases Control
N= 30 N= 30
Neck circumference (cm)
X± SD 39.64 ± 3.19 37.67 ± 2.80 t-Test
Range 34.5–44 33–44 2.55 0.01
ESS
X± SD 17.73 ± 3.30 7.97 ± 2.70 U
Range 12–23 3–12 6.63 <0.001
No % No %
Smoking
Non smokers 22 73.3 30 100 FE
Smokers 8 26.7 0 0 9.23 0.005
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Table 3 Polysomnography parameters across the studied groups.
The studied cases U test P value
Cases Control
N= 30 N= 30
Total sleep time (TST) (minute)
X± SD 281.95 ± 99.64 374.75 ± 141.19 2.54 0.01
Range 47.5–477.5 158–8.13
Sleep onset (minute)
X± SD 26.71 ± 21.99 30.55 ± 25.68 0.38 0.71
Range 0.5–79 2–88
Sleep eﬃciency
X± SD 56.63 ± 29.26 74.0 ± 14.50 2.26 0.02
Range 0.5–96.5 38–99
REM Latency from Sleep Onset (minute)
X± SD 55.78 ± 95.13 126.95 ± 108.28 2.34 0.02
Range 79–338 0–328
Spontaneous Arousals Index
X± SD 54.84 ± 29.81 32.25 ± 28.75 2.32 0.02
Range 0–102.7 4–91
Flow limitation index% total
X± SD 17.28 ± 18.69 13.67 ± 12.32 0.30 0.77
Range 0–59 0.4–48
% of sleep in supine position
X± SD 49.15 ± 33.96 57.15 ± 31.73 1.09 0.27
Range 0–100 11–100
A+H/h in supine position
X± SD 10.94 ± 17.06 6.59 ± 11.99 0.03 0.98
Range 0–61.4 0–43
PLMS sequences
X± SD 1.63 ± 2.24 0 ± 0 4.0 <0.001
Range 0–8 0–0
Average Oxygen Saturation (%)
X± SD 93.29 ± 5.26 94.05 ± 2.68 0.40 0.69
Range 77.8–99 86–99
Lowest Oxygen Saturation (%)
X± SD 82.80 ± 12.58 87.75 ± 5.49 0.61 0.55
Range 54–98 69–94
AHI
X± SD 23.42 ± 26.27 4.75 ± 8.76 2.42 0.02
Range 0–91 0–38
Oxygen Desaturation Events (OD)
X± SD 23.97 ± 25.15 3.77 ± 3.17 3.63 <0.001
Range 0–88 0–11
% of Snoring Time in TST
X± SD 9.19 ± 17.08 1.33 ± 2.63 2.41 0.02
Range 0–72.2 0–8
% of REM in TST
X± SD 15.16 ± 18.08 10.75 ± 7.85 0.36 0.72
Range 0–87.5 0–28
Total AHI in NREM
X± SD 98.63 ± 123.83 4.52 ± 8.83 3.41 <0.001
Range 0–485 0–37
Total AHI in REM
X± SD 27.90 ± 55.50 9.10 ± 12.75 0.12 0.90
Range 0–233 0–45
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Table 4 Sleep disorders by AHI among cases.
AHI Cases
N= 30
No %
Negative 12 40.0
Mild 4 13.3
Moderate 3 10.0
Sever 11 36.7
Table 5 Correlation between apnea hypopnea index and
patient investigations.
AHI among cases
r P value
Age 0.43 0.02
BMI 0.68 <0.001
Neck circumference 0.65 <0.001
ESS 0.79 <0.001
ESR 0.74 <0.001
CRP 0.73 <0.001
HCT (%) 0.72 <0.001
RF (mg/dl) 0.50 0.08
Uric acid (mg/dl) 0.44 0.02
Creatinine (mg/dl) 0.41 0.03
Table 6 Correlation between oxygen desaturation and patient
investigations.
Oxygen desaturation
r P value
Age 0.38 0.04
BMI 0.57 0.001
Neck circumference 0.43 0.02
ESS 0.60 0.001
ESR 0.57 0.001
CRP 0.68 <0.001
HCT (%) 0.78 <0.001
ANA 0.29 0.12
RF (mg/dl) 0.17 0.57
Uric acid (mg/dl) 0.21 0.28
Creatinine (mg/dl) 0.27 0.15
Table 7 Binary logistic regression analysis for independent
risk factors of SRBD.
Standard
error (SE)
Wald
X2
P
value
Odds
ratio
95%
confidence
interval (CI)
Lower Upper
ESR 0.05 3.43 0.02 1.90 1.01 4.55
CRP 0.14 0.86 0.35 1.10 0.56 1.88
RF 0.53 0.97 0.33 0.99 0.34 3.65
ANA 0.79 2.52 0.11 0.86 0.21 2.68
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influence the severity of reported symptoms of pain and fati-
gue, accelerate the risk of cardiovascular events and possibly
influence levels of circulating inflammatory markers and medi-
ators [4].
In the current work, the prevalence of Sleep apnea in CTDs
was 18/30(60%). Sleep apnea was obstructive. Mean AHI was
23.42 ± 26.27/h. Among these OSA patients, (36.7%) had
severe OSA (AHI > 30/h), (10%) had moderate OSA (AHI
15–30/h), (36.7%) had mild OSA (AHI 5–15/h).
In this study, OSA was diagnosed in 9/12(75%) of RA
patients, 5/12(42%) of SLE patients, 4/5(80%) of Behcet’s dis-
ease and 0/1(0%) of ankylosing spondylitis. The current study
results agree with those of study done by Iaboni et al. [9],which studied PSG recordings in SLE patients with disabling
fatigue. Of the 35 patients studied, 26% met criteria for sleep
apnea. This finding was in harmony with our result. Palagini
et al. [10] showed that the prevalence of OSA in the SLE
patients has ranged from 26–50%, which is considerably
higher than the general healthy persons. These findings were
in harmony with our results.
In the present work there were highly significant positive
correlations between AHI in patients and BMI (r= 0.68,
P< 0.001), Neck circumference (r= 0.65, P< 0.001), ESS
(r= 0.79, P< 0.001), ESR (r= 0.74, P< 0.001), CRP
(r= 0.73, P< 0.001), and HCT (r= 0.72, P< 0.001)
(Table 5).
It is of interest that we recorded higher levels of CRP in
CTD patients with OSA. In consistent with our study, Fouda
and Abdel Dayem [11] have demonstrated increased CRP
values among OSA patients.
In accordance with our results, Yousef and Alkhiary [12]
reported that OSAS patients had a significantly higher oxygen
desaturation index, Epworth sleepiness scale and significantly
lower minimal, basal oxygen saturation, sleep efficiency and
rapid eye movement sleep when compared to control subjects.
In addition, hematocrit was significantly higher in OSAS.
Our study also confirmed previous findings of Valencia
et al. [13] that sleep apnea, periodic limb movements (PLMS),
a poor sleep pattern (higher percentage of wake stage,
increased number of awakenings, and decreased sleep effi-
ciency) are common sleep disorders in patients with CTDs,
also Hypersomnolence was common in our CTD patients,
and can be objectively associated with total sleep time of oxy-
gen desaturation and sleep fragmentation.
Lessened sleep efficiency was a recorded polysomnographic
finding among patients, as the mean value of sleep efficiency
was (56.63 ± 29.26). In consistent with our study, several
works have demonstrated decreased sleep efficiency among
patients with ankylosing spondylitis and SLE [14,15,9].
In the present work there were significant positive correla-
tions between OD in patients and age (r= 0.38, P= 0.04)
and Neck circumference (r= 0.43, P= 0.02). In addition,
there were highly significant positive correlations between
OD in patients and BMI (r= 0.57, P= 0.001), ESS
(r= 0.60, P= 0.001), ESR (r= 0.57, P= 0.001), CRP
(r= 0.68, P< 0.001), and HCT (r= 0.78, P< 0.001).
Our results agree well with an earlier study by Peppard
et al. [16] that found BMI is an important predictor of the
severity of OD during apneic and hypopneic events of sleep-
disordered breathing, independent of age, gender, sleeping
position, smoking history, baseline SaO2 , and event duration.
660 E. EfatSerum creatinine in OSA patients was significantly higher
than controls (1.42 ± 0.50). Serum creatinine correlated
significantly with AHI (P= 0.03). This is in agreement with
the study of Bu¨chner et al. [17] who recorded that Serum
creatinine correlated significantly with AHI.
Similar to our findings, Ruiz et al. [18] found a significant
correlation between uric acid levels and some sleep parameters
(number of respiratory events, number of desaturations, or the
cumulative percentage of time with oxygen saturation less than
90%). Additionally, they showed that those patients with
severe OSAS (AHIP 30) had higher uric acid levels than
those with mild or no OSAS.
Conclusion
In conclusion, OSA is commonly associated with patients with
CTDs. These findings possibly suggest common underlying
pathological mechanisms, which may be linked to chronic
inflammation. Co-existence of OSA in CTD patients may
influence the disease activity and the level of circulating
inflammatory markers in these patients. Considering diagnosis
and treatment of this sleep disorder in CTD patients may help
improve clinical care, better prognosis and avoid rheumatoid-
associated morbidities.
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